Ideas & Insights

Join RSM at the annual Finance & Accounting for Bioscience Companies conference on Sept. 24–25 at the Marriott Cambridge Hotel in Boston.

Get yourself up to speed on the latest trends in private equity and mergers and acquisitions with the Q2 2019 HC and LS Industry Spotlight.

Skepticism regarding artificial intelligence is understandable, but it’s often based on a misunderstanding of what AI really is.

RSM’s NetSuite experience and industry knowledge helped Apellis implement a comprehensive NetSuite solution in a short timeline.

How can life sciences companies looking to go public position themselves for success? It’s all about setting the stage early on.

Get yourself up to speed on the latest trends in private equity and mergers and acquisitions with the Q1 2019 HC and LS Industry Spotlight.

Patient support programs can become a risk to life sciences product manufacturers if used to gain preferential treatment for their products.

Wearable tech’s transformative power promotes healthy lifestyles, lowers insurance coverage spending and increases employee engagement.

Life sciences organizations are collecting customer data at an enormous rate leaving them vulnerable to cyberattacks.

Tax highlights for life sciences companies as you prepare for year-end filing and a look ahead to prepare for 2019.

Healthcare-focused private equity, lending and finance conference will explore ways to successfully close transactions and achieve growth.

Rhythm Pharmaceuticals discusses how RSM helped make a success with their recent implementation of a new ERP system.

VP & Corporate Controller, John Hulburt, discusses Rhythm's recent implementation of the Microsoft Dynamics 365 ERP.

With the recent attention around speakers programs, ensure your life science organization has the proper controls in place to reduce risk.

Examine PE deals, M&A trends and the economic implications of both in the newly released 2018 Annual HC & LS Industry Spotlight.

Check out the recording below to learn how to position a security program to respond to cybersecurity threats in the life sciences industry.

RSM's industry insiders shares insights on top trends and issues affecting middle market life sciences businesses.

Bioscience insiders share why balancing science, as well as finance and accounting, is essential for growing biotechs.

Learn the key risk areas for life sciences organizations to consider as they implement controls that promote compliance and deter fraud.

See why RSM has a long record of on-time, on-budget deployments for clinical-stage companies due to our unique deployment model.